Corcept Therapeutics Inc
NASDAQ:CORT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
Fair Isaac Corp
NYSE:FICO
|
US |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
PureTech Health PLC
LSE:PRTC
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
C
|
Cello World Ltd
NSE:CELLO
|
IN |
|
H
|
Hapag-Lloyd AG
DUS:HLAG
|
DE |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
US |
|
Bank Central Asia Tbk PT
IDX:BBCA
|
ID |
|
S
|
Silla SG Co Ltd
KOSDAQ:025870
|
KR |
|
S
|
SP Group A/S
CSE:SPG
|
DK |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Resimac Group Ltd
ASX:RMC
|
AU |
|
En Japan Inc
TSE:4849
|
JP |
|
Sanmina Corp
NASDAQ:SANM
|
US |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
US |
|
Fresenius Medical Care AG
XMUN:FME
|
DE |
Bankruptcy Probability
Corcept Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corcept Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
6.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
226.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corcept Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corcept Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
